Jocelyn Kaiser
Science Magazine
Grand Haven, MI, United States
Contact Jocelyn
Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
| Recent: |
|
| Past: |
|
Past articles by Jocelyn:
CRISPR’s ‘ancestry problem’ misses cancer targets in those of African descent
Reference genomes used to direct the gene editor fail to account for human diversity → Read More
New funding effort will deploy a corps of scientist ‘scouts’ to spot innovative ideas
Hypothesis Fund will seek out promising projects in health and climate change that need seed funding → Read More
New generation of cancer-preventing vaccines could wipe out tumors before they form
Shots enter early clinical trials for healthy people at high risk for disease → Read More
Bodybuilding supplement promotes healthy aging and extends life span, at least in mice
Alpha-ketoglutarate could be safer than other potential anti-aging treatments → Read More
Designer antibodies fight cancer by tethering immune cells to tumor cells
Bispecific antibodies that bind two or more targets are the latest immunotherapy to shine in clinical trials → Read More
How does coronavirus kill? Clinicians trace a ferocious rampage through the body, from brain to toes
The lungs are ground zero for COVID-19, but blood clots may play a surprisingly big role in severe illness → Read More
After criticism, federal officials to revisit policy for reviewing risky virus experiments
Closed-door reviews of risks and benefits of studies should be made public, some scientists say → Read More
Why NIH is beefing up its data sharing rules after 16 years
Draft update to 2003 policy will require that all grantees make data sets freely available → Read More
In departure for NIH, Cancer Moonshot requires grantees to make papers immediately free
Open-access requirement diverges from usual U.S. government policy → Read More
For a decade, Francis Collins has shielded NIH—while making waves of his own
Collins has led the National Institutes of Health with a firm hand → Read More
California’s stem cell research fund dries up
Researchers hope a planned ballot initiative will renew funding in 2020 → Read More
Medical preprint server debuts
Hosted by Cold Spring Harbor Laboratory, The BMJ, and Yale University, medRxiv will invite clinical researchers to share unreviewed manuscripts → Read More
House spending panel drops U.S. ban on gene-edited babies
Change would allow the U.S. Food and Drug Administration to consider controversial treatments → Read More
New drugs that unleash the immune system on cancers may backfire, fueling tumor growth
Scientists are still debating how, and whether, drugs called checkpoint inhibitors trigger tumor "hyperprogression" → Read More
Major medical journals don’t follow their own rules for reporting results from clinical trials
Systemic look across papers finds that letters pointing out problems are often rejected → Read More
Gum disease–causing bacteria could spur Alzheimer’s
A new study finds evidence that good oral hygiene could help prevent Alzheimer’s disease. iStock.com/bernardbodo Gum disease–causing bacteria could spur Alzheimer’s By Jocelyn KaiserJan. 23, 2019 , 2:00 PM Poor oral health is a risk factor for Alzheimer’s disease. What’s not clear is whether gum disease causes the disorder or is merely a result—many patients with dementia can’t take care of… → Read More
The Alzheimer’s gamble: NIH tries to turn billions in new funding into treatment for deadly brain disease
Major windfall delivered by Congress is luring researchers from other fields to explore new ideas for stalled fight against Alzheimer’s → Read More
Plan to replicate 50 high-impact cancer papers shrinks to just 18
After 5 years, reproducibility project nears finish line → Read More
Family trees hidden in medical records could predict your disease risk
Study of 2 million New Yorkers suggests heritability for hundreds of conditions → Read More
Too much of a good thing?
As the growing wave of excitement over immunotherapies has swept through the cancer field, a concern has arisen in its wake. Are there now too many clinical trials for these novel treatments, which enlist the immune system to battle tumors? One recent tally found more than 1100 studies combining a popular new class called checkpoint inhibitor drugs, which unleash suppressed immune cells, with… → Read More